Relevant to mention, in a previous study from our group, we found that the histone methyltransferase EZH2, the catalytic subunit of the polycomb repressive complex 2 (PRC2), is upregulated during the disease course in CLL, especially at relapse [34]. The gene discussed is PRDM9; the disease is B-cell chronic lymphocytic leukemia.